STOCK TITAN

Pasithea Therapeutics: Stonepine reports 8.3% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Pasithea Therapeutics Corp. (KTTA) is the issuer named in an amended Schedule 13G reporting that Stonepine Capital Management, LLC; Stonepine Capital, L.P.; Stonepine GP, LLC; and Jon M. Plexico each beneficially own 2,774,234 common shares, or 8.3%. Each reports shared voting and dispositive power over those shares and no sole voting or dispositive power. Stonepine Capital Management is the investment adviser and Stonepine GP is the general partner of Stonepine Capital, L.P.; Plexico is the control person of Stonepine Capital Management and Stonepine GP. The reporting persons state they filed jointly but not as a group and disclaim beneficial ownership except to the extent of their pecuniary interests.

Beneficially owned common shares 2,774,234 shares Each of the four reporting persons reported this amount.
Ownership percentage 8.3% Reported by each reporting person.
Common shares outstanding 33,414,448 shares As of August 12, 2026; used to calculate the reported ownership percentage.
beneficial ownership regulatory
"Amount beneficially owned: Stonepine: 2,774,234"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Shared Voting Power regulatory
"Shared Voting Power 2,774,234"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 2,774,234"
pecuniary interest regulatory
"disclaims beneficial ownership of shares except to the extent of that person's pecuniary interest"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many KTTA shares did the reporting persons report owning?

Each of Stonepine Capital Management, LLC, Stonepine Capital, L.P., Stonepine GP, LLC, and Jon M. Plexico reported beneficial ownership of 2,774,234 Pasithea common shares, equal to 8.3% of the class. The same reported shares are attributed to each reporting person; the amounts are not stated as a combined total.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





70261F202

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage reported herein is calculated based on 33,414,448 shares of Common Stock outstanding as of August 12, 2026, as reported in the Form 10-Q filed by the Issuer on August 14, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage reported herein is calculated based on 33,414,448 shares of Common Stock outstanding as of August 12, 2026, as reported in the Form 10-Q filed by the Issuer on August 14, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage reported herein is calculated based on 33,414,448 shares of Common Stock outstanding as of August 12, 2026, as reported in the Form 10-Q filed by the Issuer on August 14, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage reported herein is calculated based on 33,414,448 shares of Common Stock outstanding as of August 12, 2026, as reported in the Form 10-Q filed by the Issuer on August 14, 2026.


SCHEDULE 13G



Stonepine Capital Management, LLC
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member
Date:11/13/2026
Stonepine Capital, L.P.
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member of the General Partner, Stonepine GP, LLC
Date:11/13/2026
Stonepine GP, LLC
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member
Date:11/13/2026
Jon M. Plexico
Signature:/s/ Jon M. Plexico
Name/Title:Reporting Person
Date:11/13/2026
Exhibit Information

AGREEMENT REGARDING JOINT FILING ON SCHEDULE 13G

Keep reading